Human papillomavirus 16 infection

Clinical trials for Human papillomavirus 16 infection explained in plain language.

Never miss a new study

Get alerted when new Human papillomavirus 16 infection trials appear

Sign up with your email to follow new studies for Human papillomavirus 16 infection, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

A randomized, Double-Blind, Placebo-Controlled phase II trial of pBI-4 plasmid administered via intramuscular TriGrid™ electroporation delivery system for treatment of women with HPV16-Positive grade 1 cervical intraepithelial neoplasia or persistent HPV16 infection

Not yet recruiting

The purpose of this study is to evaluate the safety, efficacy, and tolerability of pBI-4, an investigational therapeutic DNA vaccine, in treating adult women with Human Papillomavirus type 16 (HPV16)-positive Grade 1 cervical intraepithelial neoplasia (CIN1) or persistent HPV16 i…

Matched conditions: HUMAN PAPILLOMAVIRUS 16 INFECTION

Phase 1/2 • Sponsor: Chang Gung Memorial Hospital

Last updated Sep 09, 2026 19:00 UTC

Human papillomavirus 16 infection

Get alerted when new Human papillomavirus 16 infection trials appear

A randomized, Double-Blind, Placebo-Controlled phase II trial of pBI-4 plasmid administered via intramuscular TriGrid™ electroporation delivery system for treatment of women with HPV16-Positive grade 1 cervical intraepithelial neoplasia or persistent HPV16 infection